搜索

Ab&B Bio-Tech CO.,LTD.JS Ab&B Bio-Tech CO.,LTD.JS
Ab&B Bio-Tech CO.,LTD.JS Ab&B Bio-Tech CO.,LTD.JS
Ab&B Bio-Tech CO.,LTD.JS Ab&B Bio-Tech CO.,LTD.JS
Ab&B Bio-Tech CO.,LTD.JS Ab&B Bio-Tech CO.,LTD.JS

Why Choose Us?

Bringing global vaccine innovations to China, and delivering China's premium vaccines to the world.

quanfu quanfu

Corporate Strength

Ab&B Bio-Tech Co., Ltd. (JS) has a registered capital of 360 million yuan, with a total land area of 173 acres and a total construction area of 228,000 square meters. The No. 1 Production Park covers 69 acres, with a building area of 80,000 square meters and an investment of 1 billion yuan; the No. 2 Production Park covers 72 acres, with a building area of 120,000 square meters and an investment of 2 billion yuan; and the No. 3 Production Park covers 32 acres, with a building area of 28,000 square meters and an investment of 600 million yuan.

quanfu quanfu

Products & Services

We are committed to the full-cycle development of innovative human vaccines - from research and development through registration, industrial production to commercialization - while adhering to international standards and maintaining our focus on independent innovation.

quanfu quanfu

Scientific Research Capability

Our Shanghai and Taizhou R&D Centers with pilot-scale platforms are actively developing multiple vaccine pipelines including viral vaccines, bacterial vaccines, conjugate vaccines, recombinant subunit vaccines, and mRNA vaccines.

Product Pipelines

At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.

Listed products

Listed products

The Quadrivalent Subunit Influenza Vaccine is developed using the company's own patented technology and is in phase III clinical trial. It has the characteristics of high purity and good safety, especially suitable for children. Currently, no such products are available on the market at home and abroad.

More Product Series

Products under development

Products under development

This product uses the truncated VZV gE protein with independent intellectual property rights of our company as the antigen, and contains major B-cell and T-cell epitopes. Equipped with the self-developed dual adjuvant system, it can induce the body to produce strong specific humoral and cellular immune responses. All adjuvants used have been applied in marketed vaccines.

More Product Series

News Center

Phase I/II Clinical Trial of the Re engineered Respiratory Syncytial Virus Vaccine (CHO Cells)(Adjuvant)Officially Launched
2026-05-13

On May 13, the launch meeting for the Phase I/II clinical trial of the recombinant respiratory syncytial virus vaccine (CHO cell-based) (adjuvant) independently developed by Ab&B Bio-Tech CO.,LTD.JS. (Ab&B Bio) was successfully held at the research site in Sichuan.
→

The mRNA technology platform has achieved another milestone, with global innovation efforts accelerating.
2026-05-08

Recently, the IND application for a Class 1 new drug— "Respiratory Syncytial Virus mRNA Vaccine" —jointly submitted by Ab&B Bio-Tech Co. Ltd. JS (Ab&B Bio) and its subsidiary Yither Biotech (Shanghai) Co., Ltd. (Yither Bio) was approved by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration.
→

Our innovative vaccine research team won the 20th "Jiangsu Youth May Fourth Medal Collective" award
2026-04-27

Recently, the Communist Youth League Jiangsu Provincial Committee and the Jiangsu Provincial Department of Human Resources and Social Security officially announced the results of the 20th "Jiangsu Youth May Fourth Medal" selection. The innovative vaccine research team of Ab&B Bio-Tech Co., Ltd. JS has been awarded the honorary title of "Jiangsu Youth May Fourth Medal Collective"!
→

Got a project? Contact us today !

At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.

Contact

E-mail:haixin.zhang@yitherbiotech.com
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City

Quick view

Follow us

Copyright © 2022 Ab&B Bio-Tech CO.,LTD.JS All Rights Reserved.   Powered by:www.300.cn
Verification 苏ICP备16005775号-1
Search